Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,149,147 papers from all fields of science
Search
Sign In
Create Free Account
galtamycinone
Known as:
1,4,6-trihydroxy-10-(4,5-dihydroxy-6-methyltetrahydropyran-2-yl)-8-methyl-5,12-tetracendione
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Glycosides
Naphthacenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Unified strategy for the synthesis of C-aryl glycosides
Stephen F. Martin
2003
Corpus ID: 97916608
Abstract A unified approach for the synthesis of the four major groups of C-aryl glycosides has been developed. The strategy…
Expand
2002
2002
Efforts toward the total synthesis of 7-deoxyzaragozic acic A and galtamycinone
M. Escobar
2002
Corpus ID: 93879439
1988
1988
[Structure of galtamycin].
N. Murenets
,
M. K. Kudinova
,
N. A. Kliuev
,
A. Shashkov
,
I. V. Iartseva
Antibiotiki i khimioterapiia = Antibiotics and…
1988
Corpus ID: 6997491
Structure of galtamycin, a novel anthracycline antibiotic was assessed with 1H NMR, 13C NMR and mass spectroscopy. Galtamycin…
Expand
1986
1986
The antibiotic galtamycin. The structure of galtamycinone
Murenets Nv
,
Kudinova Mk
,
Kliuev Na
,
Chernyshev Ai
,
Shorshnev Sv
1986
Corpus ID: 76723225
The structure of galtamycinone, a chromophore moiety of galtamycin, a new antitumor antibiotic was determined by spectral…
Expand
1986
1986
[The antibiotic galtamycin. The structure of galtamycinone].
N. Murenets
,
M. K. Kudinova
,
N. A. Kliuev
,
A. Chernyshev
,
S. V. Shorshnev
Antibiotiki i meditsinskaia biotekhnologiia…
1986
Corpus ID: 39006678
The structure of galtamycinone, a chromophore moiety of galtamycin, a new antitumor antibiotic was determined by spectral…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE